0
OKYO Pharma Limited Banner Image

OKYO Pharma Limited

  • Ticker OKYO
    Exchange LSE More
  • Industry Biotechnology More
  • Sector Healthcare More
OKYO Pharma Limited Logo Image
  • 1-10 Employees
  • Based in London, England
OKYO Pharma Limited (LSE:OKYO, OCTQB:EMMLF) is a biopharmaceutical company developing next-generation therapeutics to improve the lives of patients with inflammatory eye diseases and ocular pain. Their goal is to develop first in class drug candidates that prevent the disease instead of controlling it, and they achieve this through their collaboration with pioneer scientists in the field.
OKYO Pharma Limited

Most Recent Annual Report

OKYO Pharma Limited
MOST RECENT 2021 Annual Report

Older/Archived Annual Reports